Manufacturing

Articles

Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.

Lonza, IBF Collaborate to Support Development and Manufacturing of Biologics and Small Molecules

AGC Biologics is investing in viral vector suspension technology at its new Longmont, Colo., facility.

AGC Biologics Adds Viral Vector Suspension Technology at New US Campus

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Flexible and efficient methods are needed for biopharmaceutical manufacturing. 

Demonstrating a Fully Continuous Bioprocess

Feliza Mirasol is the science editor for 

The struggle to implement continuous biomanufacturing at GMP level is slowly advancing.

Implementing Continuous Bioprocessing: From Theory to Practice

Resolving operational bottlenecks makes mAb manufacturing more efficient.

Speeding Up Development for Traditional Biologics

Mark White, PhD, is associate director, Biopharma Product Marketing, at Bio-Rad Laboratories.

Marwan Alsarraj is the Biopharma Segment manager at Bio-Rad.

Standardization is needed in CAR-T cell therapy development due to its inherent complexity.

Using ddPCR to Asses CAR-T Cell Quality

Capacity concerns and regulatory compliance considerations will drive the decision about outsourcing the manufacture of clinical trial materials.

Insights into Outsourced vs. In-house Clinical Trial Services

Recipharm has strengthened its biologics manufacturing capabilities with the acquisition of both Vibalogics and Arranta Bio.

Recipharm Acquires Two Biologics CDMOs: Vibalogics and Arranta Bio

Thermo Fisher Scientific is expanding its Millersburg, Penn., site with a $40 million investment to support increased production of single-use technology for critical vaccines and biologics.

Thermo Fisher Scientific Invests $40 Million to Expand Bioprocessing Manufacturing Site

ImmunoGen and Eli Lilly and Company have entered into an agreement that gives Lilly exclusive rights to research, develop, and commercialize ADCs designed for targets selected by Lilly from ImmunoGen’s camptothecin technology.

Manufacturing, Biologic Drugs